An essential role of the JIP1 scaffold protein for JNK activation in adipose tissue

被引:98
作者
Jaeschke, A
Czech, MP
Davis, RJ [1 ]
机构
[1] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA
[2] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA
关键词
JIP1; INK; insulin; IRS-1; obesity; diabetes;
D O I
10.1101/gad.1216504
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The c-lun NH2-terminal kinase (JNK) is activated during obesity. One consequence of obesity is that JNK phosphorylates the adapter protein insulin receptor substrate 1 (IRS-1) on Ser 307 and inhibits signaling by the insulin receptor. JNK can therefore cause peripheral insulin resistance during obesity and may contribute to the development of type 2 diabetes. Here we report that the JNK-interacting protein 1 (JIP1) scaffold protein, which binds components of the JNK signaling module, is essential for JNK activation in the adipose tissue of obese mice. These data identify JIP1 as a novel molecular target for therapeutic intervention in the development of obesity.
引用
收藏
页码:1976 / 1980
页数:5
相关论文
共 25 条
[1]   Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action [J].
Aguirre, V ;
Werner, ED ;
Giraud, J ;
Lee, YH ;
Shoelson, SE ;
White, MF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (02) :1531-1537
[2]   The c-Jun NH2-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser307 [J].
Aguirre, V ;
Uchida, T ;
Yenush, L ;
Davis, R ;
White, MF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (12) :9047-9054
[3]   JNK: a new therapeutic target for diabetes [J].
Bennett, BL ;
Satoh, Y ;
Lewis, AJ .
CURRENT OPINION IN PHARMACOLOGY, 2003, 3 (04) :420-425
[4]   The adipocyte-secreted protein Acrp30 enhances hepatic insulin action [J].
Berg, AH ;
Combs, TP ;
Du, XL ;
Brownlee, M ;
Scherer, PE .
NATURE MEDICINE, 2001, 7 (08) :947-953
[5]   Role of fatty acids in the pathogenesis of insulin resistance and NIDDM [J].
Boden, G .
DIABETES, 1997, 46 (01) :3-10
[6]   IB1, a JIP-1-related nuclear protein present in insulin-secreting cells [J].
Bonny, C ;
Nicod, P ;
Waeber, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (04) :1843-1846
[7]   A cytoplasmic inhibitor of the JNK signal transduction pathway [J].
Dickens, M ;
Rogers, JS ;
Cavanagh, J ;
Raitano, A ;
Xia, ZG ;
Halpern, JR ;
Greenberg, ME ;
Sawyers, CL ;
Davis, RJ .
SCIENCE, 1997, 277 (5326) :693-696
[8]   A central role for JNK in obesity and insulin resistance [J].
Hirosumi, J ;
Tuncman, G ;
Chang, LF ;
Görgün, CZ ;
Uysal, KT ;
Maeda, K ;
Karin, M ;
Hotamisligil, GS .
NATURE, 2002, 420 (6913) :333-336
[9]   Repression of phospho-JNK and infarct volume in ischemic brain of JIP1-deficient mice [J].
Im, JY ;
Lee, KW ;
Kim, MH ;
Lee, SH ;
Ha, HY ;
Cho, IH ;
Kim, D ;
Yu, MS ;
Kim, JB ;
Lee, JK ;
Kim, YJ ;
Youn, BW ;
Yang, SD ;
Shin, HS ;
Han, PL .
JOURNAL OF NEUROSCIENCE RESEARCH, 2003, 74 (02) :326-332
[10]   c-Jun N-terminal kinase (JNK) mediates feedback inhibition of the insulin signaling cascade [J].
Lee, YH ;
Giraud, J ;
Davis, RJ ;
White, MF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (05) :2896-2902